Form 4: Genpact Director CeCelia Morken Reports Acquisition of Restricted Share Units

Director CeCelia Morken reports acquisition of 6,707 restricted share units (RSUs) in Genpact LTD on May 2, 2024.

Summary

• CeCelia Morken, a director of Genpact LTD, reported a transaction on May 2, 2024.
• Morken acquired 6,707 restricted share units (RSUs) at a price of $0.
• Following the transaction, Morken beneficially owns 52,935 common shares.
• The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Each RSU entitles the holder to receive one common share at a future date.
• The RSUs will fully vest on December 31, 2024, subject to continued service, and will be settled in common shares on December 31, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and insider confidence, but it's not a major event.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Risks

• The value of the RSUs is tied to the future performance of Genpact's common shares, which are subject to market risks.

Future Outlook

The RSUs vesting and settlement are contingent upon the reporting person's continued service with the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, incentivizing them to work towards the company's long-term success.

Key Dates